A high MCV means your red blood cells are larger than usual, and a high MPV means your platelets are larger than usual. Neither number is a diagnosis on its own, but together they narrow the list of possibilities your doctor will consider. The causes range from something as fixable as a vitamin deficiency to something as serious as a bone marrow disorder, and the specific combination of the two values, along with the rest of your complete blood count, helps point the investigation in the right direction.
What MCV Actually Measures
MCV stands for mean corpuscular volume. It is the average size of your red blood cells, measured in femtoliters (fL). Most labs consider a normal MCV to be somewhere between about 80 and 100 fL. When MCV climbs above that range, your red blood cells are considered macrocytic, meaning they are physically bigger than they should be. The cells themselves look rounder and plumper under a microscope, and that extra size changes how well they function.
What makes a red blood cell too large? The answer almost always traces back to how the cell was built in the bone marrow. Research on macrocytosis in liver disease showed that the oversized cells are produced that way from the start: when normal-sized red blood cells were transfused into patients with macrocytosis, those transfused cells stayed normal-sized. The problem was not that circulating cells were swelling up in the bloodstream but that the bone marrow was manufacturing them bigger than normal in the first place.1Blood. The Macrocytosis of Hepatic Disease. I. Thin Macrocytosis That distinction matters because it tells clinicians to look at what is going wrong during cell production, not what is happening to cells after they are released.
The most common reasons for a high MCV include vitamin B12 or folate deficiency (which disrupts DNA synthesis in developing red blood cells), heavy alcohol use, liver disease, certain medications like methotrexate or some anti-seizure drugs, and bone marrow disorders. Hypothyroidism is sometimes mentioned as a cause, though a study comparing red blood cell indices in thyroid dysfunction found no significant difference in MCV between hypothyroid and hyperthyroid patients, suggesting the link is weaker than commonly assumed.2PubMed Central. Effect of Thyroid Dysfunctions on Blood Cell Count and Red Blood Cell Indice
What MPV Actually Measures
MPV stands for mean platelet volume. It is the average size of your platelets, also measured in femtoliters, with most labs using a reference range somewhere around 7.5 to 12 fL. Platelets are the tiny cell fragments responsible for blood clotting, and their size turns out to reflect what is happening in the bone marrow cells (called megakaryocytes) that produce them.
When your body needs to ramp up platelet production quickly, megakaryocytes tend to release larger, younger platelets. That is why MPV often rises when platelets are being consumed or destroyed faster than usual, as happens during active inflammation or clotting events. Animal research has shown that the relationship between platelet production rate and platelet size is not simple or linear: stimulating megakaryocyte growth at different intensities can either increase or decrease MPV depending on the dose and timing.3Blood. Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice In other words, a high MPV generally signals that the bone marrow is working hard to push out new platelets, but the full picture depends on what is driving that demand.
Factors that commonly raise MPV include recovery from acute blood loss, chronic inflammatory conditions, cardiovascular disease, diabetes, and some infections. Because larger platelets are more metabolically active and carry more clotting factors, a consistently elevated MPV has drawn attention as a potential marker for cardiovascular risk, which is covered further below.
When Both Are Elevated Together
Seeing a high MCV and a high MPV on the same blood test is not as unusual as it might seem. Several conditions affect both red blood cell and platelet production simultaneously, because the same bone marrow stem cells are the ancestors of both cell types. When something disrupts the bone marrow’s normal function, both lines of cells can come out bigger or more variable than normal.
Megaloblastic anemia from B12 or folate deficiency is one well-known example. When DNA synthesis is impaired, developing red blood cells grow larger before they divide, producing macrocytes. Some research has found that MPV also trends higher in megaloblastic conditions compared to other causes of low blood counts, though the difference is modest and not reliable enough to use as a standalone diagnostic tool.4PubMed. Megaloblastic pancytopenia vis-Ã -vis non-megaloblastic pancytopenia: is mean platelet volume useful discriminating indicator Interestingly, at least one study specifically looking at B12 deficiency found no statistically significant change in MPV at all, suggesting the relationship may depend on how severe the deficiency is and whether true megaloblastic changes have developed in the marrow.5Family Practice and Palliative Care. Evaluation of whole blood, mean platelet volume (MPV) and neutrophil-lymphocyte ratios (NLR) in people with B12 vitamin deficiency
Chronic liver disease and heavy alcohol use can push both numbers up through overlapping mechanisms. Alcohol is directly toxic to developing blood cells in the marrow, producing macrocytes even before liver damage sets in. The liver disease itself adds its own contribution: damaged liver cells alter erythropoiesis in a way that specifically produces large, thin red blood cells.1Blood. The Macrocytosis of Hepatic Disease. I. Thin Macrocytosis Meanwhile, portal hypertension and splenic sequestration of platelets in advanced liver disease can trigger compensatory release of larger, younger platelets from the marrow, raising MPV.
Bone marrow disorders like myelodysplastic syndromes (MDS) are another category to be aware of. MDS involves clonal stem cell abnormalities that lead to ineffective production of blood cells across multiple lineages, often resulting in both dysplastic (abnormally shaped) red blood cells and platelets.6PubMed Central. How we diagnose Myelodysplastic syndromes MCV is frequently elevated in MDS, and platelet abnormalities including changes in size and distribution are common. Aplastic anemia, where the marrow fails to produce enough cells of any type, also tends to produce macrocytic red blood cells. Research suggests this happens because the few remaining stem cells are pushed to mature and release cells faster than normal, resulting in larger-than-usual red blood cells.7PubMed Central. Complex association of mean corpuscular volume and outcomes in patients with aplastic anemia treated with cyclosporine A plus androgen or cyclosporine A alone
MPV and Cardiovascular Risk
One of the more clinically interesting developments around MPV has been its connection to cardiovascular events, particularly stroke. Larger platelets are stickier: they express more surface receptors, carry more granules packed with clotting and inflammatory chemicals, and aggregate more readily. That combination makes a person with chronically elevated MPV somewhat more prone to forming the type of clots that cause heart attacks and strokes.
A study of patients with nonvalvular atrial fibrillation found that those who went on to have an ischemic stroke had significantly higher MPV levels than those who did not. The stroke rate in the highest third of MPV values was roughly double the rate in the lowest third, and multivariate analysis confirmed MPV as an independent predictor of stroke even after accounting for other risk factors.8PubMed Central. Mean platelet volume: a new predictor of ischaemic stroke risk in patients with nonvalvular atrial fibrillation This does not mean a single high MPV reading should alarm you. The predictive value shows up in populations, not in individual blood draws. But if your doctor is assessing your overall clotting risk, MPV adds a small piece to the puzzle.
The research so far has not led to MPV-based treatment guidelines. No one is prescribing blood thinners based on MPV alone. But the association is strong enough that MPV often gets flagged in the context of patients who already have other cardiovascular risk factors like diabetes, hypertension, or atrial fibrillation.
MPV Ratios in Serious Illness
Researchers have also started combining MPV with platelet count to create a ratio (MPV divided by platelet count) that may be more informative than either number alone. A high ratio typically means platelets are large but few in number, which can reflect bone marrow stress, consumption of platelets during severe illness, or both.
In community-acquired pneumonia, patients in the highest quarter of MPV-to-platelet-count ratio had substantially higher odds of dying within 60 days compared to those in the lowest quarter, even after adjusting for other factors that predict pneumonia outcomes.9Archives of Medical Science. Usefulness of mean platelet volume to platelet count ratio for predicting the risk of mortality in community-acquired pneumonia A similar pattern appeared in patients with advanced non-small cell lung cancer, where a higher MPV-to-platelet-count ratio was closely associated with shorter survival.10Lung Cancer. Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer
These findings are prognostic rather than diagnostic. A high MPV-to-platelet-count ratio does not tell you what disease someone has, but in someone already diagnosed with a serious illness, it may help estimate how aggressive the disease course is likely to be. Most of this research is still in the observational stage, meaning it shows correlations without proving causation. But clinicians are increasingly paying attention to this ratio as one more signal among many.
Lab Artifacts That Can Fake a High MPV
Before assuming an elevated MPV is biologically meaningful, it is worth knowing that platelet size measurements are surprisingly sensitive to how the blood sample is handled in the lab. The anticoagulant used in standard blood collection tubes (EDTA) causes platelets to swell over time. Research has documented that MPV readings increase significantly within as little as 30 minutes of blood collection in EDTA tubes, regardless of which type of EDTA salt is used.11PubMed. False-positive flag of WBC and change of mean platelet volume (MPV) caused by K3-EDTA on the DxH 900 hematology analyzer The mechanism appears to involve actual cellular swelling rather than just a shape change, as light-scattering studies have confirmed that the increase in apparent volume exceeds what would be expected from platelets simply going from a disc shape to a sphere.12Thrombosis and Haemostasis. Platelet Swelling in EDTA-PRP and During pH Fall in Stored Platelet Concentrates
This means that the longer a blood sample sits before being analyzed, the higher the MPV reading will be. A sample run within minutes of collection and the same sample run two hours later can give meaningfully different results. Most labs have protocols to minimize this delay, but it does not always happen, especially in busy or understaffed settings. If your MPV is only slightly elevated and the rest of your blood count looks normal, the timing of sample processing is a legitimate explanation worth asking about.
MCV can also be affected by artifacts, though in a different way. In extreme microcytosis (when red blood cells are very small, with MCV below about 50 to 60 fL), some analyzers may miscount the tiniest red blood cells as platelets because they fall below the size threshold the machine uses to distinguish the two cell types. This can artificially inflate both the platelet count and the MPV.13Annals of Laboratory Medicine. Unreliable Automated Complete Blood Count Results: Causes, Recognition, and Resolution That particular artifact is more relevant to people with a very low MCV than a high one, but it illustrates the broader point that automated cell counters have real limitations.
What Your Doctor Will Likely Do Next
A single blood test showing elevated MCV and MPV does not typically prompt emergency action, but it will prompt follow-up questions and additional testing. The specific workup depends on how high the values are, what the rest of the blood count looks like, and your overall clinical picture.
If the elevation is mild and you have no symptoms, the most common first step is checking a few specific labs:
- Vitamin B12 and folate levels: The most treatable cause of macrocytosis. If either is low, supplementation alone can correct both the large red blood cells and any associated anemia.
- Liver function tests: Elevated liver enzymes alongside a high MCV strongly suggest liver disease or alcohol-related changes as the explanation.
- Reticulocyte count: This measures how many young red blood cells the marrow is releasing. A high reticulocyte count with a high MCV can indicate that the marrow is recovering from recent blood loss or hemolysis, since young red blood cells (reticulocytes) are naturally larger than mature ones.
- Peripheral blood smear: A technician looks at the blood under a microscope. The shape and appearance of the cells provide clues the automated analyzer cannot capture, like the presence of hypersegmented neutrophils (which point toward B12 or folate deficiency) or dysplastic cell forms (which raise concern for MDS).
- Thyroid function: Sometimes checked as part of the workup, though as noted earlier, the evidence linking thyroid dysfunction to MCV changes is weaker than often assumed.
If the initial labs do not explain the findings, or if there are other concerning features on the blood count like low white blood cell or platelet counts, a bone marrow biopsy may be recommended. That is the definitive way to diagnose marrow disorders like MDS or aplastic anemia.
For MPV specifically, there is no separate “MPV workup” in routine clinical practice. MPV is interpreted in context: alongside the platelet count, the MCV, and the clinical situation. A high MPV with a low platelet count can suggest that platelets are being destroyed or consumed (as in immune thrombocytopenia or disseminated intravascular coagulation), while a high MPV with a normal or high platelet count may suggest chronic low-grade inflammation or a myeloproliferative process.
MPV in Newborns and Infants
Normal reference ranges for MPV in adults do not apply cleanly to newborns, and this is a source of real clinical confusion. Neonates, especially those born prematurely, have platelet physiology that differs from adults in several ways. Their megakaryocytes are smaller and produce fewer platelets per cell, and the platelets they do make are somewhat different in size distribution.
An area of active research involves using MPV as an early warning sign for infection in preterm infants. A study comparing preterm newborns who developed late-onset sepsis with those who did not found that MPV was significantly higher in the sepsis group during the week before the infection was clinically apparent, and the elevation persisted for up to two weeks after the infection was identified.14PubMed Central. Mean platelet volume in preterm infants as a predictor of late-onset neonatal sepsis: a retrospective comparative study The appeal is obvious: blood counts are already drawn routinely in hospitalized preterm infants, so if MPV can flag an infection a day or two before other signs appear, it adds value without any extra cost or blood draw.
That said, interpreting MPV in neonates runs into the same pre-analytical challenges as in adults, maybe more so, because the smaller blood volumes collected from infants are processed under varying conditions. The same EDTA-related swelling that inflates MPV in adult samples applies equally to neonatal samples, and the time between collection and analysis is not always tightly controlled in neonatal intensive care settings.
Medications That Shift These Numbers
A number of commonly prescribed drugs can raise MCV independently of any underlying disease. Methotrexate, used for autoimmune conditions and some cancers, directly interferes with folate metabolism and predictably causes macrocytosis. Azathioprine and other immunosuppressants have a similar effect. Hydroxyurea, used to treat sickle cell disease and some blood cancers, raises MCV as part of its intended mechanism of action, and doctors actually monitor MCV to confirm the drug is working. Anti-seizure medications like valproic acid and phenytoin can also push MCV up, sometimes substantially.
Antiretroviral drugs used for HIV, particularly the older nucleoside reverse transcriptase inhibitors like zidovudine, are well-known causes of macrocytosis. In that setting, a rising MCV is an expected side effect rather than a sign of a new problem, though it sometimes complicates interpretation if the patient develops another condition that also affects red blood cell size.
MPV is less commonly affected by specific medications, but there are indirect effects. Any drug that causes bone marrow suppression followed by recovery can transiently raise MPV during the rebound phase, because the marrow tends to produce larger platelets when it is rebuilding. Drugs that cause chronic low-grade platelet consumption, like heparin in some patients, can also produce a compensatory elevation in MPV.
The practical takeaway is straightforward: if you are on any of these medications and your MCV or MPV is elevated, your doctor will likely attribute the finding to the drug before chasing other explanations. That does not mean the drug should be stopped, only that the blood count abnormality is expected and monitored rather than worked up further.
Why These Values Get Overlooked
Despite the growing body of research connecting MCV and MPV to clinically meaningful outcomes, these values are among the most frequently ignored numbers on a complete blood count. Most clinicians focus on the “big three” of hemoglobin, white blood cell count, and platelet count. MCV gets attention if it is very high or the patient is anemic, but MPV is often not even reported by default on automated blood counts in some health systems.
Part of the reason is standardization. MCV measurement has been stable and reliable for decades, but MPV measurement varies depending on the instrument, the anticoagulant, and the time delay before analysis. Two different analyzers running the same blood sample can give MPV values that differ by more than a femtoliter, which is clinically significant when the entire normal range spans only about 4 to 5 fL. Until labs standardize MPV measurement more tightly, many clinicians remain cautious about acting on it. The research showing MPV’s prognostic value in stroke, pneumonia, and cancer is compelling at the population level, but translating it into care decisions for individual patients remains a work in progress.